A vascular modulator, hepatocyte growth factor, is associated with systolic pressure

Hypertension

Volumn 28, Issue 3, 1996, Pages 409-413

  Nakamura, Yoshio ^a   Morishita, Ryuichi ^a   Nakamura, Shigefumi ^a   Aoki, Motokuni ^a   Moriguchi, Atsushi ^a   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b   Higaki, Jitsuo ^a   Ogihara, Toshio ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

atherosclerosis; growth factors, endothelial; growth substances; vascular remodeling

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; FEMALE; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TISSUE REGENERATION; VASODILATATION;

EID: 0029816543     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.409     Document Type: Article

References (46)

1. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of atrial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 1990;346:69-71.
2. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. Possible existence of 'vascular natriuretic peptide system.' J Clin Invest. 1992;90:1145-1149.
3. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990; 86:1690-1697.
4. Cohn JM, Finkelstein SM. Abnormalities of vascular compliance in hypertension, aging and heart failure. J Hypertens. 1992;10(suppl 6):561-564.
5. Lockette W, Otsuka Y, Carretero OA. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension. 1986;8 (suppl II):II-61-II-66.
6. Diedrich D, Yang Z, Buhler FR, Luscher TF. Impaired endothelium-dependent relaxation in hypertensive resistance arteries involves cyclooxygenase pathway. Am J Physiol. 1988;258:H445-H451.
7. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
8. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991;18(suppl III):III-115-III-121.
9. Krieger JE, Dzau VJ. Molecular biology of hypertension. Hypertension. 1991;18(suppl I):I-3-I-17.
10. Dzau VJ. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle cells and cardiac myocytes. Curr Opin Nephrol Hypertens. 1993;2:27-32.
11. Nakamura Y, Morishita R, Higaki J, Kida J, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, Nakamura T. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun. 1995;215:483-488.
12. Matsumoto K, Tashiro K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β and glucocorticoids. J Biol Chem. 1992;267:24917-24920.
13. Okajima A, Miyazawa K, Kitamura N. Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene. Eur J Biochem. 1993;213:113-119.
14. Liu Y, Michalopoulos G, Zarnegar R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem. 1994;269:4152-4160.
15. Gohda E, Matsunaga T, Kataoka H, Yamamoto I. TGF-β is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int Rep. 1992;16:917-926.
16. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. In: Goldberg ID, Rosen EM, eds. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and C-Met Receptor. Basel, Switzerland: Birkhauser Verlag; 1993:225-249.
17. Hamanoue M, Takao S, Shimazu H, Noji S, Matsumoto K, Nakamura T. Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology. 1992; 16:1485-1492.
18. Nagaike M, Hirao S, Tajima H, Noji S, Taniguchi S, Matsumoto K, Nakamura T. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem. 1991; 266:22781-22784.
19. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol. 1993;265:F61-F69.
20. Ito T, Hayashi N, Horimoto M, Sasaki Y, Tanaka Y, Kaneko A, Fusamoto H, Kamada T. Expression of the c-met/hepatocyte growth factor receptor gene during rat liver regeneration induced by carbon tetrachloride. Biochem Biophys Res Commun. 1993;190:870-874.
21. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res. 1991;3:67-86.
22. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 1991;16:1227-1235.
23. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357-4361.
24. Libby P, O'Brien KV. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol. 1983;115: 217-223.
25. +: the implication of a protective role of αB-crystallin accumulation in reactive glia. Brain Res. 1995;673:47-52.
26. Shirahata S, Watanabe J, Teruya K, Yano T, Osada K, Ohashi H, Tachibana H, Kim EH, Murakami H. E1A and ras oncogenes synergistically enhance recombinant protein production under control of the cytomegalovirus promoter in BHK-21 cells. Biosci Biotech Biochem. 1995;59:345-347.
27. Ohtake T, Kano S, Iri H. Evaluation of microparticle latex immunoassay for serum Lp(a) on Hitachi 7070 analyzer. Clin Chem. 1994;40:1102. Abstract.
28. Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, Nakamura T. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res. 1995;16:105-114.
29. Nakamura T, Hagiya M, Nishizawa T, Seki T, Shimonishi M, Sugiura A, Tashiro K, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342:440-443.
30. Seki T, Ihara I, Sugiyama M, Nishizawa T, Asami O, Hagiya M, Nakamura T, Shimizu S. Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocytes. Biochem Biophys Res Commun. 1990;172:321-327.
31. Tashiro K, Hagiya M, Nishizawa T, Seki T, Shimonishi M, Shimizu S, Nakamura T. Deduced primary structure of hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci U S A. 1990;87:3200-3204.
32. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet. 1995;345:293-295.
33. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 1989;8:3801-3806.
34. Ferrara N, Winer J, Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors. 1991;5:141-148.
35. Rakugi H, Gibbons GH, Wang D, Billingham M, Vershave K, Feruson J, Angelini P, Hogan P, Massumi A, Buja LM, Blubb F, McAllister H, Willerson H, Dzau VJ. Expression of transforming growth factor beta 1 in human atherectomy specimens from primary and restenotic coronary artery lesions. J Am Coll Cardiol. 1992; 19:329A. Abstract.
36. Nikol S, Isner M, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 1992;90:1582-1592.
37. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension. 1992;19(suppl II):II-62-II-67.
38. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension. 1990; 15:68-77.
39. Okamura T, Miyazaki M, Inagami T, Toda N. Vascular renin angiotensin system in two-kidney, one clip hypertensive rats. Hypertension. 1986;8: 560-565.
40. Sarzani R, Brecher P, Chobanian AV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest. 1989; 83:1404-1498.
41. Liepins A, Bustamante JO. Cell injury and apoptosis. Scanning Microsc. 1994;8:641-643.
42. Hamet P. Proliferation and apoptosis of vascular smooth muscle in hypertension. Curr Opin Nephrol Hypertens. 1995;4:1-7.
43. Hamet P, Richard L, Dam TV, Teiger E, Orlov SN, Gaboury L, Gossard F, Tremblay J. Apoptosis in target organs of hypertension. Hypertension. 1995;26:642-648.
44. Psaty BM, Furberg CD, Kuller LH, Borhani NO, Rautaharju PM, O'Leary DH, Bild DE, Robbins J, Fried LP, Reid C. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly: initial findings from the Cardiovascular Health Study. JAMA. 1992; 268:1287-1291.
45. Bots ML, Hofman A, de Bruyn AM, de long PT, Grobbee DE. Isolated systolic hypertension and vessel wall thickness of the carotid artery: The Rotterdam Elderly Study. Arterioscler Thromb. 1993; 13:64-69.
46. Koren MJ, Mensah GA, Blake J, Laragh JH, Devereux RB. Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. Am J Hypertens. 1993;6: 815-823.